SalubrisBio
About:
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Website: https://www.salubrisbio.com
Top Investors: Shenzhen Salubris Pharmaceuticals
Description:
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Total Funding Amount:
$102M
Headquarters Location:
Gaithersburg, Maryland, United States
Founded Date:
2016-01-01
Contact Email:
SalubrisBio(AT)argotpartners.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2024-04-22
IPO Status:
Private
Industries:
© 2025 bioDAO.ai